We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

WuXi PharmaTech Completes Construction of New Biosafety Testing Facility

News   May 13, 2014

 
WuXi PharmaTech Completes Construction of New Biosafety Testing Facility
 
 
Advertisement
 

RELATED ARTICLES

Probiotic Yeast Engineered To Produce Beta-Carotene

News

In order to produce beta-carotene in the guts of laboratory mice, researchers have genetically engineered a probiotic yeast. The advance demonstrates the utility of work the researchers have done to detail how a suite of genetic engineering tools can be used to modify the yeast.

READ MORE

Adhesive Patch Delivers Blood Vessel-Forming Factors to Damaged Tissues

News

A research team has bioengineered a novel adhesive patch platform that can efficiently deliver blood vessel-forming growth factors using a bio-adhesive material that is made from mussels harmless to humans.

READ MORE

Personalized Cancer Vaccine Shows Early Efficacy in Patients With Diverse Tumor Types

News

Treatment with the neoantigen cancer vaccine PGV-001 following standard-of-care adjuvant therapy was well tolerated and demonstrated potential clinical benefit in patients with diverse tumor types according to a Phase 1 study. The findings were reported during the virtual AACR Annual Meeting 2021.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE